These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34893414)

  • 1. Lifetime risk of cardiovascular disease and life expectancy with and without cardiovascular disease according to changes in metabolic syndrome status.
    Li D; Wang L; Zhou Z; Song L; Chen S; Yang Y; Hu Y; Wang Y; Wu S; Tian Y
    Nutr Metab Cardiovasc Dis; 2022 Feb; 32(2):373-381. PubMed ID: 34893414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between cumulative metabolic risk exposure and cardiovascular disease: a nationwide cohort of over 3.6 million young adults.
    Lee H; Rhee TM; Park HE; Han K; Choi SY
    Eur J Prev Cardiol; 2024 Aug; 31(10):1288-1300. PubMed ID: 38421612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study.
    Ramezankhani A; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2022 Nov; 21(1):227. PubMed ID: 36324143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan.
    Lai YJ; Yen YF; Chen LJ; Hsu LF; Ahmadi MN; Inan-Eroglu E; Ku PW; Stamatakis E
    Diabetes Metab; 2023 May; 49(3):101415. PubMed ID: 36563960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Health Status and Metabolic Syndrome in Adults Living in a Transition European Country: Findings from a Population-Based Study.
    Stojisavljević D; Janković J; Erić M; Marinković J; Janković S
    J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):568-574. PubMed ID: 29097061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ideal Cardiovascular Health Metric and Its Change With Lifetime Risk of Cardiovascular Diseases: A Prospective Cohort Study.
    Wang L; Song L; Li D; Zhou Z; Chen S; Yang Y; Hu Y; Wang Y; Wu S; Tian Y
    J Am Heart Assoc; 2021 Nov; 10(22):e022502. PubMed ID: 34755533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High normotension is associated with future metabolic syndrome but not cardiovascular disease: A 10-year longitudinal study.
    Chen YL; Hsu CH; Hsieh CH; Wu CZ; Lin JD; Chang JB; Liang YJ; Tsai YT; Hsia TL; Pei D
    Medicine (Baltimore); 2017 Jun; 96(25):e7227. PubMed ID: 28640118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex.
    Matsubayashi Y; Fujihara K; Yamada-Harada M; Mitsuma Y; Sato T; Yaguchi Y; Osawa T; Yamamoto M; Kitazawa M; Yamada T; Kodama S; Sone H
    Cardiovasc Diabetol; 2022 Jun; 21(1):90. PubMed ID: 35655263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status: A Nationwide Population-Based Study of Approximately 10 Million Persons.
    Park S; Lee S; Kim Y; Lee Y; Kang MW; Han K; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    Ann Intern Med; 2019 Dec; 171(12):875-884. PubMed ID: 31766057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Age of Metabolic Syndrome Onset With Cardiovascular Diseases: The Kailuan Study.
    Huang Z; Wang X; Ding X; Cai Z; Li W; Chen Z; Fang W; Cai Z; Lan Y; Chen G; Wu W; Chen Z; Wu S; Chen Y
    Front Endocrinol (Lausanne); 2022; 13():857985. PubMed ID: 35370968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic Changes of Metabolic Syndrome Alter the Risks of Cardiovascular Diseases and All-Cause Mortality: Evidence From a Prospective Cohort Study.
    He D; Zhang X; Chen S; Dai C; Wu Q; Zhou Y; Jin Z; Wu S; Zhu Y
    Front Cardiovasc Med; 2021; 8():706999. PubMed ID: 34422932
    [No Abstract]   [Full Text] [Related]  

  • 12. The relationship of metabolic syndrome and constitutional medicine for the prediction of cardiovascular disease.
    Cho NH; Kim JY; Kim SS; Shin C
    Diabetes Metab Syndr; 2013; 7(4):226-32. PubMed ID: 24290090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term metabolic fate and mortality in obesity without metabolic syndrome.
    Käräjämäki AJ; Korkiakoski A; Hukkanen J; Kesäniemi YA; Ukkola O
    Ann Med; 2022 Dec; 54(1):1432-1443. PubMed ID: 35594302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of expression of selenoprotein P in mRNA and protein levels with metabolic syndrome in subjects with cardiovascular disease: Results of the Selenegene study.
    Gharipour M; Sadeghi M; Salehi M; Behmanesh M; Khosravi E; Dianatkhah M; Haghjoo Javanmard S; Razavi R; Gharipour A
    J Gene Med; 2017 Mar; 19(3):. PubMed ID: 28190280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of detailed components of metabolic syndrome associated with the risk of cardiovascular disease and death.
    Lin TY; Chien KL; Chiu YH; Chuang PC; Yen MF; Chen HH
    Sci Rep; 2021 Feb; 11(1):3677. PubMed ID: 33574366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project.
    Vishram JK; Borglykke A; Andreasen AH; Jeppesen J; Ibsen H; Jørgensen T; Palmieri L; Giampaoli S; Donfrancesco C; Kee F; Mancia G; Cesana G; Kuulasmaa K; Salomaa V; Sans S; Ferrieres J; Dallongeville J; Söderberg S; Arveiler D; Wagner A; Tunstall-Pedoe H; Drygas W; Olsen MH;
    PLoS One; 2014; 9(9):e107294. PubMed ID: 25244618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between metabolic syndrome severity score and cardiovascular disease: results from a longitudinal cohort study on Chinese adults.
    Lin JJ; Dai PY; Zhang J; Guan YQ; Gong WW; Yu M; Fang L; Hu RY; He QF; Li N; Wang LX; Liang MB; Zhong JM
    Front Endocrinol (Lausanne); 2024; 15():1341546. PubMed ID: 38654930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk and Age of Cardiovascular Event in Women with Metabolic Syndrome: Menopause Age in Focus.
    Soleimani A; Pourmoghaddas A; Sadeghi M; Roohafza H; Talaei M; Dianatkhah M; Oveisgharan S; Soleimani M; Sarrafzadegan N
    Metab Syndr Relat Disord; 2018 Apr; 16(3):127-134. PubMed ID: 29437523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between metabolic syndrome and 10-year risk of developing cardiovascular disease in a Nigerian population.
    Oguoma VM; Nwose EU; Skinner TC; Richards RS; Digban KA; Onyia IC
    Int Health; 2016 Sep; 8(5):354-9. PubMed ID: 27118483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.